OPEN SOURCE PHARMA
  • Home
  • Who We Are
    • Vision & Mission
    • In The News
    • This Website
  • Why We Need OSP
    • Articles
    • Group Blog
  • Projects
  • Conferences
    • Paris 2019
    • Germany
    • Bellagio
  • Forum
  • Resources
  • Get Involved
  • Donate

WHY WE NEED
​OPEN SOURCE ​PHARMA

We asked scientists, entrepreneurs, and activists why the time was right for open source pharmaceuticals.
​Click on the authors' names below to read what they had to say.
​BY JAMES ARINAITWE

Global Health Corps & Aspen
​Institute Fellow / Kampala
​
​
"The beauty of Open Source Pharma is that, first, it brings important ideas and data together in a forum not controlled by patent laws"
​
Picture
BY ELS TORREELE

​DirECTOR of Access to
Essential Medicines
Initiative, Open Society
​Foundations / NYC
"Instead of viewing medicines as proprietary luxury goods that are owned by private companies, medicines could be public or social goods"
​

BY JOHN WILBANKS

​Chief Commons Officer
of ​Sage Bionetworks /
Washington, D.C.

​
"The pharmaceutical industry is broken.
Every year, it spends more money to discover fewer drugs than before, and the drugs that do make it to market are priced at levels that exclude all but the very wealthy from access."
​

​"Medicine for all. That is our simple message"
​ BY MANICA BALesEGARAM
​
ExecUTIVE Director, Access
Campaign, Médecins Sans
​Frontières / Geneva​
​
"We need to fundamentally let go of thinking that there is only one possible business model. We need alternatives"
​

BY DIMITRIOS TZALIS
​
Founder & CEO of Taros ​
Chemicals / ​Dortmund
​
​
"The pharmaceutical industry has consistently met the medical needs of developed societies, but played a detrimental role in tackling major diseases"
​
BY TOMASZ SABLINSKI

CEO of Transparency Life
Sciences / NYC​
"Fantastic progress in science has not led to enough new medications"

Picture
BY MATTHEW TODD

​Founder of Open Source
Malaria / Sydney & Cambridge

​
"Something could be found in radical openness"
Picture
BY ZAKIR THOMAS

​Open innovation expert &
Former Project Director
​of OSDD / Delhi

​
"The funding pattern of innovation for neglected diseases points to the need for alternative models in drug development"
​
BY POLLY J. PRICE 

Emory University law
professor / ​Atlanta​
​
​"We must find a better way to combat the rising, world-wide threat from drug-resistant tuberculosis"
​
BY T.V MOHANDIS PAI

Chairman of Manipal Global
​Education Services / Bangalore
​
​
"It is essential that we recreate the compassion of the past and the spirit that put human lives first, before commercial interests, and create an ecosystem where individuals and groups can come together in an open system, to create new drugs to eliminate diseases and save lives"
​
Join the discussion!

"How open-source medicine could prepare us for the next pandemic"
- Fast Company

see article

"Why we need Open Source Pharma -- voices from Atlanta to Delhi speak up"​ - By Open Source Pharma on THUNDERCLAP

See article

GET INVOLVED   |   SUPPORT OUR WORK

Stay up to date

​Who We Are
Vision & Mission Statement
About this Site
Why We Need OSP
Group Blog

Projects
​Conferences
Forum
Resources
Get Involved
Donate

Contact Us:
info@opensourcepharma.net
Nodes of Activity:
Bangalore - Boston - Chicago - Kozhikode - ​London - Marburg - Montreal - Mumbai - New York - Paris - Toronto - San Francisco
This site is maintained by the Open Source Pharma Foundation
Picture
  • Home
  • Who We Are
    • Vision & Mission
    • In The News
    • This Website
  • Why We Need OSP
    • Articles
    • Group Blog
  • Projects
  • Conferences
    • Paris 2019
    • Germany
    • Bellagio
  • Forum
  • Resources
  • Get Involved
  • Donate